Long-term outcome and alloantibody production in a non-myeloablative region for induction of renal allograft tolerance

Transplantation

Volumn 68, Issue 11, 1999, Pages 1767-1775

  Kawai, Tatsuo ^a   Poncelet, Alain ^b   Sachs, David H ^a   Mauiyyedi, Shamila ^a   Boskovic, Svetlan ^a   Wee, Siew Lin ^a   Ko, Dicken S C ^a   Bartholomew, Amelia ^c   Kimikawa, Masaaki ^d   Hong, Han Zhou ^a   Abrahamian, Gregory ^a   Colvin, Robert B ^a   Cosimi, A Benedict ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BONE MARROW TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033572899     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912150-00022     Document Type: Article

References (31)

1. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C for the international mycophnolate mofetil renal transplant study groups. Mycophenolate Mofetil in renal allograft recipients. A pooled efficiency analysis of three randomized, double blinded, clinical studies in prevention of rejection. Transplantation 1997; 63: 39.
2. Mathew TH for the tricontinental mycophenolate mofetil renal transplantation study group. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Transplantation 1998; 65: 1450.
3. Thomas JM, Verbanac KM, Smith JP. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245.
4. Knechtle SJ, Vargo DJ, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997; 63: 1.
5. Armstrong N, Buckley P, Oberley T, et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 1998; 66: 5.
6. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and antiCD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94: 8789.
7. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med 1999; 5: 686-693.
8. Yang YG, deGoma E, Ohdan H, et al. Tolerization of anti-Gala1-3Gal natural antibody-forming B cell by induction of mixed chimerism. J.Exp.Med 1998; 187: 1335.
9. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 1995; 60: 971.
10. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
11. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
12. Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. 1997. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 64:709.
13. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of non-human primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
14. Russell PS, Chase C, Colvin RB, Plate J. Kidney transplants in mice: An analysis of the immune status of mice bearing long-term H-2 incompatible transplants. J Exp Med 1978; 147: 1449.
15. Coleman DV, Mackenzie EF, Gardner SD, Poulding JM, Am B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol 1978; 31: 338.
16. van Gorder MA, Pelle PD, Henson JW, Sachs DH, Cosimi AB, Colvin RB. 1998. Cynomolgus polyomavirus infection: A new member of the polyomavirus family (CPV) causes interstitial nephritis, ureteritis and enteritis in immunosuppressed Cynomolgus monkeys. Am J Pathol 1999; 154: 1273.
17. Haas Gs, Halperin E, Dosertz D, et.al. The effects of cyclosporine and lymphoid irradiation on allograft survival and peripheral blood T cells. Heart Transplant 1984; 3: 152.
18. Stuart FP, Reckard CR, Ketel BL, Schulak JA. Effect of splenectomy on first cadaver kidney transplants. Ann.Surg. 1980; 192: 553.
19. Peters TG, Williams JW, Harmon HC, Britt LG. Splenectomy and death in renal transplant patients. Arch Surg.1983; 118: 795.
20. Severyn W, Kyriakides G, Fuller L, et al. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring. Surgery 1981; 90: 364.
21. Alexander JW, First MR, Majeski JA, Munda R, Fidler JP, Morris MJ. The late adverse effect of splenectomy on patient survival following cadaveric renal transplantation. Transplantation. 1984; 37: 467.
22. Sutherland DER, Fryd DS, So SKS, et al. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Transplantation. 1984; 38: 619.
23. Alexandre GPJ, Squifflet JP, DeBruyere M. Splenectomy as a preequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17: 138.
24. Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF. Current experiences with renal transplantation across the ABO barrier. Am J Surg 1992; 164: 541.
25. Yamaguchi Y, Goto M, Makino Y, Kikuchi N, Hamaguchi H, Hisama N. Prolonged survival of rat hepatic allografts pretreated with a single blood transfusion:the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. J Surg. Res. 1996; 61: 23.
26. Shelby J, Wakely E, Corry RJ. Suppressor cell induction in donor specific transfused mouse heart recipients. Surgery. 1984; 96: 296.
27. Balshi JD, Perloff LJ. Splenectomy and donor-specific blood transfusion in rat allografts. Transplantation 1986; 41: 118.
28. Ford WL. Lymphocyte migration and immune responses. Prog Allergy 1975; 19: 1.
29. Sprent J Miller JFAP, Mitchell GF. Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol 1971; 2: 171.
30. Armitage RJ, Fanslow WC, Strockbine L, et al. molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80.
31. Banchereau J, P.De Paoli A, Garcia E, Rousset F Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70.